Annual Accounts Payable
$11.54 M
+$5.13 M+80.07%
December 31, 2023
Summary
- As of February 26, 2025, SYRS annual accounts payable is $11.54 million, with the most recent change of +$5.13 million (+80.07%) on December 31, 2023.
- During the last 3 years, SYRS annual accounts payable has risen by +$7.94 million (+220.40%).
- SYRS annual accounts payable is now at all-time high.
Performance
SYRS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.65 M
+$2.18 M+29.15%
September 30, 2024
Summary
- As of February 26, 2025, SYRS quarterly accounts payable is $9.65 million, with the most recent change of +$2.18 million (+29.15%) on September 30, 2024.
- Over the past year, SYRS quarterly accounts payable has stayed the same.
- SYRS quarterly accounts payable is now -25.90% below its all-time high of $13.02 million, reached on September 30, 2022.
Performance
SYRS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SYRS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.1% | 0.0% |
| 3 y3 years | +220.4% | +245.1% |
| 5 y5 years | +248.9% | +245.1% |
SYRS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +212.7% | -25.9% | +245.1% |
| 5 y | 5-year | at high | +220.4% | -25.9% | +245.1% |
| alltime | all time | at high | +1144.0% | -25.9% | +663.7% |
Syros Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.65 M(+29.1%) |
| Jun 2024 | - | $7.47 M(-34.2%) |
| Mar 2024 | - | $11.35 M(-1.7%) |
| Dec 2023 | $11.54 M(+80.1%) | $11.54 M(+304.3%) |
| Sep 2023 | - | $2.85 M(-57.3%) |
| Jun 2023 | - | $6.69 M(+139.5%) |
| Mar 2023 | - | $2.79 M(-56.4%) |
| Dec 2022 | $6.41 M(+73.6%) | $6.41 M(-50.7%) |
| Sep 2022 | - | $13.02 M(+112.6%) |
| Jun 2022 | - | $6.12 M(+115.6%) |
| Mar 2022 | - | $2.84 M(-23.0%) |
| Dec 2021 | $3.69 M(+2.5%) | $3.69 M(-10.1%) |
| Sep 2021 | - | $4.11 M(+11.9%) |
| Jun 2021 | - | $3.67 M(+0.3%) |
| Mar 2021 | - | $3.66 M(+1.6%) |
| Dec 2020 | $3.60 M | $3.60 M(-27.1%) |
| Sep 2020 | - | $4.94 M(+76.2%) |
| Jun 2020 | - | $2.80 M(-39.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $4.64 M(-20.8%) |
| Dec 2019 | $5.85 M(+76.9%) | $5.85 M(-27.2%) |
| Sep 2019 | - | $8.04 M(+357.2%) |
| Jun 2019 | - | $1.76 M(-33.2%) |
| Mar 2019 | - | $2.63 M(-20.5%) |
| Dec 2018 | $3.31 M(+44.9%) | $3.31 M(+23.9%) |
| Sep 2018 | - | $2.67 M(+111.5%) |
| Jun 2018 | - | $1.26 M(-26.4%) |
| Mar 2018 | - | $1.72 M(-24.8%) |
| Dec 2017 | $2.28 M(-5.5%) | $2.28 M(+23.7%) |
| Sep 2017 | - | $1.85 M(+36.9%) |
| Jun 2017 | - | $1.35 M(-43.3%) |
| Mar 2017 | - | $2.38 M(-1.6%) |
| Dec 2016 | $2.42 M(-52.0%) | $2.42 M(-40.2%) |
| Sep 2016 | - | $4.04 M(+145.5%) |
| Jun 2016 | - | $1.65 M(-27.2%) |
| Mar 2016 | - | $2.26 M(-55.1%) |
| Dec 2015 | $5.04 M(+442.6%) | $5.04 M |
| Dec 2014 | $928.00 K | - |
FAQ
- What is Syros Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual accounts payable year-on-year change?
- What is Syros Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly accounts payable year-on-year change?
What is Syros Pharmaceuticals annual accounts payable?
The current annual accounts payable of SYRS is $11.54 M
What is the all time high annual accounts payable for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual accounts payable is $11.54 M
What is Syros Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, SYRS annual accounts payable has changed by +$5.13 M (+80.07%)
What is Syros Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of SYRS is $9.65 M
What is the all time high quarterly accounts payable for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly accounts payable is $13.02 M
What is Syros Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, SYRS quarterly accounts payable has changed by $0.00 (0.00%)